💨 Abstract
Black Diamond Therapeutics, Inc. (BDTX) reported a second-quarter loss of $10.6 million, or 19 cents per share, beating Wall Street's expectations of a 25 cents per share loss. The company's shares closed at $2.69, down from $5.01 a year ago. The report was generated by Automated Insights using data from Zacks Investment Research.
Courtesy: WTOP Staff
Suggested
United Airlines tech issue that impacted more than 1,000 flights resolved, residual delays expected -
El exintérprete de Superman dice que se une a ICE y respalda la ofensiva migratoria de Trump -
Helicopter crashes just outside Kenya’s capital -
Grains higher, livestock lower -
RFK Jr.’s vow to overhaul vaccine injury program echoes grievances of anti-vaccine movement -
Prosecutors in Thailand issue indictments for dozens in deadly building collapse -
Tejon: Q2 Earnings Snapshot -
Click-to-Cancel Could’ve Made Canceling Subscriptions Easier: Here’s How to Protect Yourself Without It -
Congress member says US will push Israel to withdraw from Lebanon if the army secures the country -
Saga: Q2 Earnings Snapshot -